The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Krystal Biotech, Inc(NASDAQ:KRYS) 
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullo...
Website: http://www.krystalbio.com
Founded: 2015
Full Time Employees: 51
Sector: Healthcare
Industry: Biotechnology
Krystal Biotech Days Payable Outstanding ttm (DPO)
Krystal Biotech Days Receivable Outstanding ttm (DSO)
Krystal Biotech Days Inventory Outstanding ttm (DIO)
Krystal Biotech Op Cashflow Per Share ttm
Krystal Biotech Free Cashflow Per Share ttm
Krystal Biotech Cash Per Share ttm
Krystal Biotech P/S ratio ttm
Krystal Biotech (GAAP) P/E ratio ttm
Krystal Biotech P/B ratio ttm
No extra charts and metrics for this ticker.